Bio-Rad rolls out SARS CoV-2 standards for Coronavirus Testing
Category: #health  | By Nikita Chaurasia  | Date: 2020-03-13 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Bio-Rad rolls out SARS CoV-2 standards for Coronavirus Testing
  • The SARS CoV-2 standard has human genomic DNA and synthetic COVID-19 RNA transcripts.
     
  • SARS CoV-2 standard assists laboratories to keep up with the soaring demand for the identification of Coronavirus by helping validate COVID-19 tests.

Amidst the unprecedented fear of Coronavirus (COVID-19), Bio-Rad Laboratories, Inc. has announced the launch of a SARS CoV-2 standard to underpin laboratory assay validation of COVID-19 testing. The testing will be part of its Exact Diagnostics product line as the company is offering the SARS CoV-2 standard to aid labs to expedite access to testing and authenticate their COVID-19 assay results.

The SARS CoV-2 standard has human genomic DNA and synthetic COVID-19 RNA transcripts, thereby enabling laboratories to test the total process of a molecular assay such as amplification, extraction and detection of the virus.

It is worth noting that the (CLIA) Clinical Laboratory Improvement Amendments federal regulatory standards need clinical laboratories to document and build their own specifications of performance meant for test developed in laboratory to make precise and accurate results before the test is implemented.

Dara Wright, Bio-Rad Executive Vice President, highlighted the significance of labs to have access to aptly-defined standards to assist with the authentication of the tests in case of a public health emergency.

Wright stressed that the SARS CoV-2 standard assists laboratories to keep up with the soaring demand for the identification of Coronavirus by helping validate COVID-19 tests.

The press release shared by Bio-Rad states that the Exact Diagnostics product line develops and manufactures an array of innovatively designed molecular diagnostics products to keep abreast with the needs of quality control of assay manufacturers and clinal labs.

Underpinned by offering quality products and services to labs and manufacturers, the diagnostic products intend to improve patient care by helping to assure the validity of screening tests and diagnostic results.

Source credit:

https://www.bio-rad.com/en-in/corporate/newsroom/bio-rad-announces-that-through-its-exact-diagnostics-product-line-company-has-launched-sars-cov-2-standard-for-coronavirus-covid-19-testing?ID=Bio-Rad-Announces-th_1584057675

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Fintech firm PayPal to shed around 2000 staff as global economy plummets

Fintech firm PayPal to shed around 2000 staff as global economy plummets

By Nikita Chaurasia

PayPal, the U.S.-based fintech giant, has reportedly announced that it will cut nearly 2000 jobs, approximately 7% of its workforce, as it turns the latest prominent tech company to shed staff in a bid to cut costs. The online payments provider cl...

EasyJet sees a rise in bookings as customers plan their next vacations

EasyJet sees a rise in bookings as customers plan their next vacations

By Nikita Chaurasia

British multinational low-cost airline group, EasyJet, has reported a record surge in bookings for the month of January as people prioritized their travel plans for the coming year. The news comes as airlines world over start to show signs that they&...

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

By Nikita Chaurasia

Dr. Reddy's Laboratories Ltd. and Cipla Ltd. surpassed Aurobindo Pharma to rank as the 2nd and 3rd largest drug manufacturers in India by sales in the three months that ended on September 30. This was the first change in the pecking order of the ...